CS1-SPECIFIC SINGLE-DOMAIN ANTIBODIES LABELED WITH ACTINIUM-225 PROLONG SURVIVAL AND INCREASE CD8+ T CELLS AND PD-L1 EXPRESSION IN MULTIPLE MYELOMA

CS1-specific single-domain antibodies labeled with Actinium-225 prolong survival and increase CD8+ T cells and PD-L1 expression in Multiple Myeloma

Multiple myeloma (MM) is a hematological malignancy characterized by the presence of clonal plasma cells in the bone marrow niche.Despite significant therapeutic advances, MM remains incurable for the majority of patients.Targeted radionuclide therapy (TRNT) has emerged as a promising treatment option to eradicate residual cancer cells.In this stud

read more